Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ELVNONC

Enliven Therapeutics, Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ELVN

43/100

ONC

74/100

Quality

Is it a profitable, well-run business?

ELVN

2.0/10

ONC

4.6/10

Growth

Is the company growing?

ELVN

0.0/10

ONC

9.8/10

Valuation

Is the price reasonable? (higher = cheaper)

ELVN

0.0/10

ONC

3.4/10

Risk

How risky are the shares? (higher = lower risk)

ELVN

4.9/10

ONC

7.6/10

Momentum

Is the share price trending up?

ELVN

5.5/10

ONC

9.4/10

Financial strength

Is the balance sheet healthy?

ELVN

7.5/10

ONC

8.1/10

The balanced view

Model-generated

Enliven Therapeutics, Inc.

This company scores below average, with supportive analyst views and a healthy balance sheet, although its current valuation deserves attention.

Leads on: no single area

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: valuation may be demanding (P/E (TTM): -25.3x)

BeOne Medicines AG

This company scores above average, with solid growth and a positive price trend, although its current valuation deserves attention.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: solid growth (Revenue growth (FY): 40.2%)

Watch out: valuation may be demanding (DCF upside: -1062.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.